Evidence map›Paper›PMID 30744651›Full record

ArticleMolecular brain2019

DA-JC1 improves learning and memory by antagonizing Aβ31-35-induced circadian rhythm disorder.

Li Wang, Rui Zhang, Xiaohong Hou, Changtu Wang, Shuai Guo, Na Ning, Cong Sun, Yuan Yuan, Lin Li, Christian Hölscher and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular brain, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Li WangDepartment of Pathology, Shanxi Medical University, Taiyuan, People's Republic of China.
Rui ZhangDepartment of Pathology, Shanxi Medical University, Taiyuan, People's Republic of China.
Xiaohong HouDepartment of Pathology, Shanxi Medical University, Taiyuan, People's Republic of China.
Changtu WangDepartment of Pathology, Shanxi Medical University, Taiyuan, People's Republic of China.
Shuai GuoDepartment of Pathology, Shanxi Medical University, Taiyuan, People's Republic of China.
Na NingDepartment of Pathology, Shanxi Medical University, Taiyuan, People's Republic of China.
Cong SunDepartment of Pathology, Shanxi Medical University, Taiyuan, People's Republic of China.
Yuan YuanLaboratory of Morphology, Department of Basic Medical Sciences, Shanxi Medical University, Taiyuan, People's Republic of China.
Lin LiKey Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, People's Republic of China.
Christian HölscherSecond Hospital, Shanxi Medical University, Taiyuan, People's Republic of China.
Xiaohui WangDepartment of Pathology, Shanxi Medical University, Taiyuan, People's Republic of China. 163.wangxh@163.com.ORCID 0000-0002-5053-1008
Shanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies have shown that a normal circadian rhythm is crucial to learning and memory. Circadian rhythm disturbances that occur at early stages of Alzheimer's disease (AD) aggravate the progression of the disease and further reduce learning and memory in AD patients. The novel, dual GLP-1R/GIPR agonist DA-JC1 has been found to exert a stronger hypoglycemic effect than a GLP-1R agonist alone and has been shown to exert neuroprotective effects. However, it is not clear whether DA-JC1 improves the Aβ31-35-induced decline in learning and memory ability by restoring disrupted circadian rhythms. In the present study, we carried out a mouse wheel-running experiment and Morris water maze test (MWM) and found that DA-JC1 could effectively improve the decline of learning and memory and circadian rhythm disorders induced by Aβ31-35. After downregulating Per2 expression via lentivirus-shPer2 in the hippocampus and the hippocampal HT22 cells, we found that circadian rhythm disorders occurred, and that DA-JC1 could not improve the impaired learning and memory. These results suggest that DA-JC1 improves damage to learning and memory by antagonizing circadian rhythm disorders induced by Aβ31-35. The outcome of this ongoing study may provide a novel therapeutic intervention for AD in the future.

Indexed as

Amyloid beta-PeptidesAnimalsCell LineChronobiology DisordersCircadian RhythmGAP-43 ProteinGene SilencingHippocampusLentivirusMaleMemoryMice, Inbred C57BLNeuronsPeptide FragmentsPeptidesPeriod Circadian ProteinsAmyloid beta-Peptidesamyloid beta-protein (31-35)GAP-43 ProteinPeptide FragmentsPeptidesPeriod Circadian ProteinsSynaptophysinAβ31–35Circadian rhythmDA-JC1Learning and memory

Identifiers

PMID30744651
PMCPMC6371467
OpenAlexW2920903885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.